Skip to main content

2024 Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

An M. Vermeulen, PhD

Senior Director and CPP Immunology Group Leader and Fellow
Johnson & Johnson Innovative Medicine, Belgium

Poster(s):

052: Nipocalimab Pharmacokinetic/Pharmacodynamic & Exposure-Response Modeling in Pregnancies at Risk for Early-onset Severe (EOS) HDFN

Sunday, September 8, 2024
5:00 PM – 7:00 PM ET
060: Pharmacokinetic Modeling of the IRF5 Antisense Oligonucleotide JNJ-66525433 & IRF5 mRNA Expression in Healthy Individuals

Sunday, September 8, 2024
5:00 PM – 7:00 PM ET
166: Fetal & Neonatal Drug Exposure Following Nipocalimab Treatment in Pregnant Women at Risk of EOS-HDFN

Monday, September 9, 2024
5:00 PM – 7:00 PM ET